These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7039985)

  • 21. [Use of isometric load for evaluation of the anti-arrhythmia effect of drugs].
    Gel'fgat EB; Abdullaev RF; Danilova VA; Khalilov AN
    Kardiologiia; 1988 Dec; 28(12):66-8. PubMed ID: 2468809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ECG monitoring via telephone for the assessment of patients with symptoms suggestive of arrhythmias].
    Klootwijk AP; Roelandt JR
    Ned Tijdschr Geneeskd; 1983 Mar; 127(13):545-9. PubMed ID: 6843702
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnosis and management of cardiac rhythm disorders by transtelephonic electrocardiography in infants and children.
    Dick M; McFadden D; Crowley D; Rosenthal A
    J Pediatr; 1979 Apr; 94(4):612-5. PubMed ID: 430303
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recurrent ventricular tachycardia studied by Holter's method (author's transl)].
    Faniel R; Friart J
    Rev Med Brux; 1980 Mar; 1(3):165-8. PubMed ID: 6162180
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrocardiographic markers of repolarization heterogeneity during dofetilide or sotalol initiation for paroxysmal atrial fibrillation.
    Sauer AJ; Kaplan R; Xue J; Dorsey P; Hayes M; Shah SJ; Passman R
    Am J Cardiol; 2014 Jun; 113(12):2030-5. PubMed ID: 24793679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Heart frequency control in chronic and paroxysmal atrial fibrillation. Critical evaluation of traditional therapy concepts].
    Ostermaier R; von Essen R
    Fortschr Med; 1997 Jan; 115(1-2):26-8, 30, 32, passim. PubMed ID: 9102378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of telemedicine in the diagnosis of paroxysmal atrial fibrillation and to monitor the effect of antiarrhythmic drug therapy.
    Klingenheben T; Israel CW
    Herzschrittmacherther Elektrophysiol; 2006 Dec; 17(4):225-8. PubMed ID: 17211755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current principles of the diagnosis and treatment of paroxysmal tachycardia].
    Smetnev AS; Shevchenko NM
    Kardiologiia; 1986 Apr; 26(4):5-8. PubMed ID: 3712952
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antiarrhythmic drug therapy and prevention of cardiac emergencies in the prehospital phase].
    von Knorre GH
    Z Arztl Fortbild (Jena); 1984; 78(15):621-2. PubMed ID: 6495771
    [No Abstract]   [Full Text] [Related]  

  • 30. Adenosine: an effective and safe antiarrhythmic drug in pediatrics.
    Paul T; Pfammatter JP
    Pediatr Cardiol; 1997; 18(2):118-26. PubMed ID: 9049125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transition of paroxysmal ventricular tachycardia into sinus rhythm under the effect of gilurytmal].
    Vasić V
    Med Glas; 1971 Jan; 25(1):32-5. PubMed ID: 5133974
    [No Abstract]   [Full Text] [Related]  

  • 33. Indications and techniques for ambulatory electrocardiogram monitoring.
    Schroeder JS; Fitzgerald JW
    Heart Lung; 1975; 4(4):540-5. PubMed ID: 1042008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of isoptin in angina pectoris and heart rhythm disorders].
    Doshchitsyn VL; Arshakuni RO; Zharov EI
    Kardiologiia; 1967 Aug; 7(8):32-40. PubMed ID: 4182174
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of propafenone hydrochloride on atrial signal-averaged ECG in patients with paroxysmal atrial fibrillation].
    Telichowski A; Banasiak W; Ponikowski P; Wiech K; Zebrowski J; Pieróg M; Kałka D; Lacheta W; Fuglewicz A; Molenda W
    Pol Arch Med Wewn; 1995 Aug; 94(2):132-43. PubMed ID: 8596748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous ECG (Holter) recordings in the evaluation of antiarrhythmic drugs.
    Bleifer DJ; Hansmann DR; Bleifer SB; Sheppard JS; Karpman HL
    Schweiz Med Wochenschr; 1974 Nov; 104(44):1585-6. PubMed ID: 4138545
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience in the clinical use of etmozin in different cardiac rhythm disturbances].
    Mazur NA; Liakishev AA; Kubanov RD
    Kardiologiia; 1980 Jul; 20(7):44-9. PubMed ID: 6157047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
    Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanism of action and the effectiveness of ethacizin in patients with paroxysmal atrioventricular nodal reciprocal tachycardia].
    Malakhov VI; Shugushev KhKh
    Kardiologiia; 1986 Apr; 26(4):48-54. PubMed ID: 3520090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.